🔥🐔 BizChicken 🐔🔥
Companies Similar to BioMarin Pharmaceutical Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Kiromic BioPharma, Inc.
ALEXIS-ISO-1, ALEXIS-PRO-1
Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.
Symbol: KRBP
Recent Price: $0.93
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Sector: Healthcare
Employees: 35
Address: 7707 Fannin, Houston, TX 77054
Phone: 832 968 4888
Leadership
- Pietro Bersani, CPA, Director
- Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
- Scott Dahlbeck, MD, PharmD, Chief of Staff
- Brian Hungerford, Chief Financial Officer
- Michael Nagel, Chairperson
- Michael Catlin, Independent Director
- Pam Misajon, Independent Director
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Vaccinex, Inc.
pepinemab
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.
Contact | Contact | Careers | About | Careers | About | About | About | About | About | News | Events | About | About | ESG | About | About | About | About | About
Symbol: VCNX
Recent Price: $1.11
Industry: Biotechnology
CEO: Dr. Maurice Zauderer Ph.D.
Sector: Healthcare
Employees: 37
Address: 1895 Mount Hope Avenue, Rochester, NY 14620
Phone: 585 271 2700
Last updated: 2024-12-31
Abivax SA American Depositary Shares
obefazimod
ABIVAX Société Anonyme is a clinical-stage biotechnology company developing therapeutics to modulate the immune response for chronic inflammatory diseases. Their lead drug candidate, obefazimod, is in Phase 3 clinical trials for ulcerative colitis.
About | Vision/Values | History | Leadership | Contact | About | About
Symbol: ABVX
Recent Price: $7.05
Industry: Biotechnology
CEO: Mr. Marc M. P. de Garidel M.B.A.
Sector: Healthcare
Employees: 62
Address: 7-11 boulevard Haussmann, Paris, null 75009
Phone: 33 1 53 83 09 63
Leadership
- Marc de Garidel, MBA, Chief Executive Officer
- Didier Blondel, EVP, Chief Financial Officer & Board Secretary
- Fabio Cataldi, MD, Chief Medical Officer
- Ida Hatoum, Chief People Officer, Chief Compliance Officer
- David Zhang, PhD, Chief Strategy Officer
- Pierre Courteille, Pharmacist, MBA, Chief Business Officer
- Didier Scherrer, PhD, Chief Scientific Officer
- Jérôme Denis, PhD, EVP, Process Development & Manufacturing
- Nadège Briancon-Eris, PhD, Senior Vice President, Global Head of Program Management
- Sylvie Grégoire, PharmD, Chair of the Board
- Corinna zur Bonsen-Thomas, Co-founder and CEO of RetInSight; Former General Counsel at Baxter/Baxalta International
- Philippe Pouletty, MD, Founder of Abivax; Managing Partner of Truffle Capital
- June Lee, MD FACCP, Venture Partner at 5AM Ventures
- Kinam Hong, MD, MBA, CFA, Partner at the Crossover Fund Sofinnova
- Troy Ignelzi, CFO of Rapport Therapeutics
- Camilla Soenderby, Board Member of BB Biotech, F2G, and Affibody; Member of Novo Holdings Advisory Group; Industrial Advisor for EQT
- Mary Mantock, Senior Vice President, Global Head of Regulatory Affairs
- Hema Keshava, Senior Vice President, Finance
- Cristina Damatarca, MD, PgD, Senior Vice President, Global Head of Drug Safety and Pharmacovigilance
- Patrick Malloy, Senior Vice President, Investor Relations
- Douglas Jacobstein, MD, Senior Vice President, Global Head of Clinical Development
- Jennifer Fine, ScD, Senior Vice President, Global Head of HEOR and RWE
- Kevin Shan, PhD, Vice President, Global Head of Biometrics
- Chris Rabbat, PhD, Vice President, Global Head of Medical Affairs
- Ana Sharma, MPH, Vice President, Global Head of Quality
- Sophie LaCourrege, Vice President, HR Business Partner, Engagement and Culture
Last updated: 2024-12-31
BeiGene, Ltd.
BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy
Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.
About | About | Vision/Values | About | About | Culture | DEI | Culture | Leadership | About | Contact | Careers | Careers | Careers | Careers | About | About | About | About | About | Jobs | About | About | About
Symbol: BGNE
Recent Price: $183.81
Industry: Biotechnology
CEO: Mr. John V. Oyler
Sector: Healthcare
Employees: 10000
Address: 55 Cambridge Parkway, Cambridge, MA 02142
Phone: 781-801-1800
Leadership
- John V. Oyler, Co-Founder, Chairman and CEO
- Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
- Olivier Brandicourt, M.D., Director
- Margaret Dugan, M.D., Director
- Donald W. Glazer, Director
- Michael Goller, Director
- Anthony Hooper, Director
- Ranjeev Krishana, Director
- Michael Nuoqing Yi, Director
- Alessandro Riva, M.D., Director
- Corsee Sanders, Ph.D., Director
- Shalini Sharp, Director
- Steven Young, Ph.D., Acting Head of Medicinal Chemistry
- Ron Levy, M.D., Scientific Advisory Board
- Neal Rosen, M.D., Ph.D., Scientific Advisory Board
- Charles Sawyers, M.D., Scientific Advisory Board
- David Schenkein, M.D., Scientific Advisory Board
- Melika Davis, SVP & Global Head, Clinical Operations
- Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
- Tony Guo, Ph.D., SVP, Global Statistics & Data Science
- Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
- Graham Hardiman, Global Head of HR
- Shreya Devendra Jani, SVP, Corporate Affairs
- Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
- Yang Ji, Chief Compliance Officer
- Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
- Chan Lee, General Counsel
- Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
- Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
- Kyoung Lim, VP of Supply Chain
- Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
- Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
- Richard O’Keeffe, Head of Global Quality
- Jurij Petrin, M.D., Head of New Market Development
- Yan Qi, Ph.D., SVP, Head of Public Affairs
- Hongyu Qian, SVP, Medical Affairs
- Jason Radford, SVP, Strategy & Corporate Development
- Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
- Adam Roach, VP and Head of Asia Pacific
- Aaron Rosenberg, Chief Financial Officer
- Michael Schoen, Strategic Advisor and Special Assistant to the CEO
- Matt Shaulis, General Manager of North America
- Lai Wang, Ph.D., Global Head of R&D
- Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
- Beth Wensley, SVP, Head of Portfolio and Program Management
- Kimberly Wolf, SVP, Global Commercial Strategy & Operations
- Xiaobin Wu, Ph.D., President, Chief Operating Officer
- Eva Yin, Chief Commercial Officer, Greater China
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
BioMarin Pharmaceutical Inc.
Vimizim
Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.
About | Leadership | Directors | About | About | About | Locations | Contact | About | Careers | Careers | Benefits | Careers | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Jobs | Site Map | About | About | About | About | About | About | About | About
Symbol: BMRN
Recent Price: $65.45
Industry: Biotechnology
CEO: Mr. Alexander Hardy
Sector: Healthcare
Employees: 3401
Address: 770 Lindaro Street, San Rafael, CA 94901
Phone: 415 506 6700
Leadership
- Mark Enyedy,
- Alexander Hardy,
- Elaine J. Heron,
- G. Eric Davis, Executive Vice President, Chief Legal Officer
- Greg Friberg, Executive Vice President, Chief Research & Development Officer
- C. Greg Guyer, Executive Vice President, Chief Technical Officer
- Cristin Hubbard, Executive Vice President, Chief Commercial Officer
- Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
- Brian R. Mueller, Executive Vice President, Chief Financial Officer
- James Sabry, Executive Vice President, Chief Business Officer
- Amy Wireman, Executive Vice President, Chief People Officer
- Richard A. Meier,
- Elizabeth McKee Anderson,
- Barbara Bodem,
- Athena Countouriotis,
- Willard H. Dere,
- Maykin Ho,
- Robert J. Hombach,
- David E.I. Pyott,
Last updated: 2024-12-31
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Mirum Pharmaceuticals, Inc.
LIVMARLI
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for rare and orphan diseases, with products like LIVMARLI and Volixibat.
Symbol: MIRM
Recent Price: $41.18
Industry: Biotechnology
CEO: Mr. Christopher Peetz
Sector: Healthcare
Employees: 294
Address: 950 Tower Lane, Foster City, CA 94404
Phone: 650 667 4085
Leadership
- Chris Peetz, Chief Executive Officer, Mirum Pharmaceuticals
- Erin Campany, Senior Vice President, Human Resources
- Eric Bjerkholt, Chief Financial Officer
- Jean-Luc Girardet, Ph.D., Senior Vice President, Technical Operations
- Vinita Kumar, Senior Vice President, Quality
- Lara Longpre, Chief Development Officer
- Joanne Quan, M.D., Chief Medical Officer
- Peter Radovich, President & Chief Operating Officer
- Paul Ross, Chief Compliance Officer
- Pamela Vig, Ph.D., Chief Scientific Officer and Head of Research
- Laura Brege, Board Member
- Patrick Heron, Managing General Partner, Frazier Healthcare Partners
- Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
- Lon Cardon, Ph.D., FMedSci., Board Member
- William C. Fairey, Board Member
- Laurent Fischer, M.D., President & Chief Executive Officer, Adverum Biotechnologies
- Mike Grey, Chairman of the Board, Mirum Pharmaceuticals
- Saira Ramasastry, MS, MPhil, Managing Partner, Life Sciences Advisory, LLC
Last updated: 2024-12-31
MediciNova, Inc.
MN-166 (ibudilast)
Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.
Symbol: MNOV
Recent Price: $2.11
Industry: Biotechnology
CEO: Dr. Yuichi Iwaki M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 858 373 1500
Leadership
- Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
- Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
- David H. Crean, Ph.D., Chief Business Officer
- Jason J. Kruger, CPA (inactive), Chief Financial Officer
- Hideki Nagao, Member of the Board of Directors
- Carolyn Beaver, Member of the Board of Directors
- Nicole Lemerond, CFA, Member of the Board of Directors
Last updated: 2024-12-31
Maravai LifeSciences Holdings, Inc.
Nucleic Acids and Biologics Safety Testing Products
Maravai Life Sciences Holdings, Inc. is a life sciences company that provides products for drug therapies, diagnostics, novel vaccines, and research on human diseases, serving both the United States and international markets.
Symbol: MRVI
Recent Price: $5.51
Industry: Biotechnology
CEO: Mr. William E. Martin III
Sector: Healthcare
Employees: 580
Address: 10770 Wateridge Circle, San Diego, CA 92121
Phone: 858 546 0004
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31
Virios Therapeutics, Inc.
IMC-1
Virios Therapeutics, Inc. is a biotechnology company focused on developing antiviral therapies for diseases associated with a viral triggered abnormal immune response, including fibromyalgia and long COVID.
Symbol: VIRI
Recent Price: $0.15
Industry: Biotechnology
CEO: Mr. Gregory Duncan
Sector: Healthcare
Employees: 4
Address: 44 Milton Avenue, Alpharetta, GA 30009
Phone: 866 620 8655
Last updated: 2024-12-31